Literature DB >> 11078741

Core LXXLL motif sequences in CREB-binding protein, SRC1, and RIP140 define affinity and selectivity for steroid and retinoid receptors.

D M Heery1, S Hoare, S Hussain, M G Parker, H Sheppard.   

Abstract

An alpha-helical motif containing the sequence LXXLL is required for the ligand-dependent binding of transcriptional co-activators to nuclear receptors. By using a peptide inhibition assay, we have defined the minimal "core" LXXLL motif as an 8-amino acid sequence spanning positions -2 to +6 relative to the primary conserved leucine residue. In yeast two-hybrid assays, core LXXLL motif sequences derived from steroid receptor co-activator (SRC1), the 140-kDa receptor interacting protein (RIP140), and CREB-binding protein (CBP) displayed differences in selectivity and affinity for nuclear receptor ligand binding domains. Although core LXXLL motifs from SRC1 and RIP140 mediated strong interactions with steroid and retinoid receptors, three LXXLL motifs present in the global co-activator CBP were found to have very weak affinity for these proteins. Core motifs with high affinity for steroid and retinoid receptors were generally found to contain a hydrophobic residue at position -1 relative to the first conserved leucine and a nonhydrophobic residue at position +2. Our results indicate that variant residues in LXXLL core motifs influence the affinity and selectivity of co-activators for nuclear receptors.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11078741     DOI: 10.1074/jbc.M009404200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  42 in total

1.  Downregulation of RIP140 in hepatocellular carcinoma promoted the growth and migration of the cancer cells.

Authors:  Dexiang Zhang; Yueqi Wang; Yuedi Dai; Jiwen Wang; Tao Suo; Hongtao Pan; Han Liu; Sheng Shen; Houbao Liu
Journal:  Tumour Biol       Date:  2014-11-13

2.  PPARs and lipid ligands in inflammation and metabolism.

Authors:  Gregory S Harmon; Michael T Lam; Christopher K Glass
Journal:  Chem Rev       Date:  2011-10-12       Impact factor: 60.622

3.  Differential gene regulation by selective association of transcriptional coactivators and bZIP DNA-binding domains.

Authors:  Benoit Miotto; Kevin Struhl
Journal:  Mol Cell Biol       Date:  2006-08       Impact factor: 4.272

4.  LXXLL-related motifs in Dax-1 have target specificity for the orphan nuclear receptors Ad4BP/SF-1 and LRH-1.

Authors:  Taiga Suzuki; Megumi Kasahara; Hidefumi Yoshioka; Ken-Ichirou Morohashi; Kazuhiko Umesono
Journal:  Mol Cell Biol       Date:  2003-01       Impact factor: 4.272

5.  CrkL is a co-activator of estrogen receptor alpha that enhances tumorigenic potential in cancer.

Authors:  Renjini Ambika Padmanabhan; Lini Nirmala; Megha Murali; Malini Laloraya
Journal:  Mol Endocrinol       Date:  2011-06-23

6.  Mechanisms of progesterone receptor inhibition of inflammatory responses in cellular models of breast cancer.

Authors:  Sakiko Kobayashi; James P Stice; Dmitri Kazmin; Bryan M Wittmann; Erin A Kimbrel; Dean P Edwards; Ching-Yi Chang; Donald P McDonnell
Journal:  Mol Endocrinol       Date:  2010-10-27

Review 7.  Leucine-rich repeat protein PRAME: expression, potential functions and clinical implications for leukaemia.

Authors:  Frances Wadelin; Joel Fulton; Paul A McEwan; Keith A Spriggs; Jonas Emsley; David M Heery
Journal:  Mol Cancer       Date:  2010-08-27       Impact factor: 27.401

8.  ARF represses androgen receptor transactivation in prostate cancer.

Authors:  Wenfu Lu; Yingqiu Xie; Yufang Ma; Robert J Matusik; Zhenbang Chen
Journal:  Mol Endocrinol       Date:  2013-02-28

9.  Transcriptional corepressor SMILE recruits SIRT1 to inhibit nuclear receptor estrogen receptor-related receptor gamma transactivation.

Authors:  Yuan-Bin Xie; Jeong-Hoh Park; Don-Kyu Kim; Jung Hwan Hwang; Sangmi Oh; Seung Bum Park; Minho Shong; In-Kyu Lee; Hueng-Sik Choi
Journal:  J Biol Chem       Date:  2009-08-18       Impact factor: 5.157

10.  Molecular characterization of SMILE as a novel corepressor of nuclear receptors.

Authors:  Yuan-Bin Xie; Balachandar Nedumaran; Hueng-Sik Choi
Journal:  Nucleic Acids Res       Date:  2009-05-08       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.